Evaluation of Bone Height Gain Following Trans-crestal Sinus Floor Elevation
Maxillary Sinus Disease
About this trial
This is an interventional treatment trial for Maxillary Sinus Disease
Eligibility Criteria
Inclusion Criteria:
● Patients having one missing upper posterior tooth with residual bone height beneath maxillary sinus from 5-8 mm.
- A minimum of 6 mm residual bone width at site of implant placement.
- The recipient site of the implant should be free from any pathological conditions.
- No diagnosed bone disease or medication known to affect bone metabolism.
- Patients who are cooperative, motivated and hygiene conscious.
- Patients having adequate inter-occlusal space of 8-10 mm
Exclusion Criteria:
● Systemic conditions/diseases that contraindicate surgery.
- Radiation therapy in the head and neck region or chemotherapy during the 12 months prior to surgery.
- Patients who have any habits that might jeopardize the osseointegration process, such as current smokers.
- Patients with parafunctional habits that produce overload on implant, such as bruxism and clenching.
- Patients that have any pathology in the maxillary sinuses.
Sites / Locations
- Cairo University
- Faculty of Dentistry
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Densah bur
Ostetome
According to the protocol for densah burs. The direction was reversed and the cutting speed was raised to 1200 rpm after the initial perforation close to the sinus floor. After that, two densifying burs were used in succession to elevate the sinus membrane by 2 mm and prepare the implant hole to the desired implant size.
Flat end osteotome of appropriate size will be introduced through the osteotomy to infracture the floor of the sinus by light malleting.